About this trial
This is a prospective, intervention-based, non-randomized, pre-post, single-site feasibility study that will involve data collection from individuals with intractable tinnitus. The study comprises a screening under local anesthesia and a surgery to implant the medical device. The screening will allow for accurate selection of patients. For patients not fulfilling the criteria for chronic extracochlear stimulation, the study will stop there. Patients eligible for chronic stimulation will undergo a second surgery under general anaesthesia involving the implantation of a cochlear implant with an electrode placed outside the cochlea in the vicinity of the round window. Each surgical procedure will be followed by a series of medical check-ups. Following implantation, the safety and efficiency of extracochlear chronic stimulation will be evaluated as well as the tinnitus suppression and speech perception.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years
Proficient in written and spoken Dutch, defined by self-report or the researcher
Intractable severe/uncompensated unilateral tinnitus, evaluated by VAS-score, and confirmed by Tinnitus functionality Index (TFI) and Tinnitus Questionnaire (TQ) (global TFI score of 54 and above and global TQ-score of 47 and above)
Suffering from tinnitus for at least a year
Disqualifiers
Chronic middle ear pathology
Surgical anatomy not allowing for implantation, evaluated by CBCT/MRI imaging
Tinnitus suppression is possible to achieve with hearing aids (as per self-report/documentation)
Clinically significant depression (HADS-score of 11 and above)
Trial design
Single group
Treatments tested in this trial
Extracochlear stimulation
DeviceThe study will implant a cochlear implant extracochlearly, near the round window.
Treatment groups
Trial outcomes
Primary outcomes
Number of participants with treatment-related adverse events
The primary objective of this clinical feasibility study is to evaluate safety of the cochlear implant system when implanted extracochlear, near the round window. The number of adverse events in each participant will be reported.
Hearing loss
The primary objective of this clinical feasibility study is to evaluate safety, and usability of the cochlear implant system when implanted extracochlear, near the round window. This includes no major deterioration of hearing thresholds. Hearing thresholds will be measured by pure tone audiometry.
Tinnitus suppression
Demonstrate the efficiency of extracochlear electrical stimulation for tinnitus suppression after 6 and 12 months after chronic extracochlear electrical stimulation.The change in self-reported tinnitus severity after 12 months of chronic extracochlear electrical stimulation evaluated with the VAS-scores for tinnitus intensity and annoyance, and the TQ and TFI questionnaires.
Secondary outcomes
speech perception in quiet and in noise
Evaluate the effect on speech perception and sound quality of extracochlear electrical stimulation in the region of the round window at 12 months after implantation of the device.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: